dr megan carter glp 1 ⚡ It's time for this week's Friday Featured Friend! ⚡ Today, I am highlighting the incredible Karen Shields-Phillips who is the ACNO at Emory Orthopaedics and Spine Hospital and VP of Procedural… My Insurance Won't Cover GLP-1

2025 Jul;33(7):1232-1236

The Role of Compounded Medications For many, accessing weight loss support involves looking at various options

The expanded FDA approvals of GLP1 drugs for cardiovascular disease, metabolic-associated steatohepatitis (MASH) 9 and potentially other comorbidities (other renal, respiratory and neurological conditions) has broadened access to new patient populations

1 2 Calanna S, Christensen M, Holst JJ, Laferrre B, Gluud LL, Vilsbll T, Knop FK (May 2013)

The upregulation of UCP-1, PPAR and PGC-1, together with the increased mtDNA content and cytochrome c oxidase activity, occurred in a SIRT1-dependent manner with exenatide treatment